Wednesday, September 23, 2020
Covid-19 vaccine: Johnson & Johnson begins Phase-3 trial with 60k people
With the move, J&J becomes the tenth maker globally to conduct a Phase 3 trial against Covid-19, and the fourth in the US.
from Hindustan Times - world https://ift.tt/32UkcLw
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment